- Volume 15 Issue 24
DOI QR Code
Role of PET/CT in Treatment Planning for Head and Neck Cancer Patients Undergoing Definitive Radiotherapy
- Arslan, Sonay (Department of Radiation Oncology, Diyarbakir Gazi Yasargil Education and Research Hospital) ;
- Abakay, Candan Demiroz (Department of Radiation Oncology, Uludag University, Faculty of Medicine) ;
- Sen, Feyza (Department of Nuclear Medicine, Uludag University, Faculty of Medicine) ;
- Altay, Ali (Department of Radiation Oncology, Uludag University, Faculty of Medicine) ;
- Akpinar, Tayyar (Department of Nuclear Medicine, Uludag University, Faculty of Medicine) ;
- Ekinci, Ahmet Siyar (Department of Medical Oncology, Diyarbakir Gazi Yasargil Education and Research Hospital) ;
- Esbah, Onur (Department of Medical Oncology, Diyarbakir Gazi Yasargil Education and Research Hospital) ;
- Uslu, Nuri (Department of Radiation Oncology, Diyarbakir Gazi Yasargil Education and Research Hospital) ;
- Kekilli, Kezban Esra (Department of Radiation Oncology, Bursa Ali Osman Sonmez Oncology Hospital) ;
- Ozkan, Lutfi (Department of Radiation Oncology, Uludag University, Faculty of Medicine)
- Published : 2015.01.22
Background: In this study, we aimed to investigate the benefits of 18F-deoxyglucose positron emission tomography/computed tomography (FGD-PET/CT) imaging for staging and radiotherapy planning in patients with head and neck cancer undergoing definitive radiotherapy. Materials and Methods: Thirty-seven head and neck cancer patients who had undergone definitive radiotherapy and PET/CT at the Uludag University Medical Faculty Department of Radiation Oncology were investigated in order to determine the role of PET/CT in staging and radiotherapy planning. Results: The median age of this patient group of 32 males and 5 females was 57 years (13-84years). The stage remained the same in 18 cases, decreased in 5 cases and increased in 14 cases with PET/CT imaging. Total gross tumor volume (GTV) determined by CT (GTVCT-Total) was increased in 32 cases (86.5%) when compared to total GTV determined by PET/CT (GTVPET/CT-Total). The GTV of the primary tumor determined by PET/CT (GTVPET/CT) was larger in 3 cases and smaller in 34 cases compared to that determined by CT (GTVCT). The GTV of lymph nodes determined by PET/CT (GTVLNPET/CT) was larger in 20 cases (54%) and smaller in 12 cases (32.5%) when compared to GTV values determined by CT (GTVLNCT). No pathological lymph nodes were observed in the remaining five cases with both CT and PET/CT. Conclusions: We can conclude that PET/CT can significantly affect both pretreatment staging and assessed target tumor volume in patients with head and neck cancer. We therefore recommend examining such cases with PEC/CT before treatment.
- American Joint Committee On Cancer (2010). AJCC Cancer Staging Manual Seventh Edition. Springer.
- Chapman Jd, Bradley Jd, Eary Jf, et al (2003). Molecular (Functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys, 55, 294-301. https://doi.org/10.1016/S0360-3016(02)04215-3
- Connell CA, Corry J, Milner AD, et al (2007). Head Neck. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck, 29, 986-95. https://doi.org/10.1002/hed.20629
- Daisne JF, Duprez T, Weynand B, et al (2004). Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology, 233, 93-100 https://doi.org/10.1148/radiol.2331030660
- Deantonio L, Beldi B, Gambaro G, et al (2008). FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiation Oncology, 3, 29. https://doi.org/10.1186/1748-717X-3-29
- Demir B, Okutan M, Demir M (2009). Pozitron emisyon tomografi ve radyoterapi tedavi planlama. Turk Onkoloji Dergisi, 24, 88-97.
- Guido A, Fuccio L, Rombi B, et al (2009). Combined 18F-Fdg-Pet/Ct Imaging In Radiotherapy Target Delineation For Head-And-Neck Cancer. Int J Radiation Oncology Biol Phys, 73,759-63. https://doi.org/10.1016/j.ijrobp.2008.04.059
- Heron DE, Andrade RS, Flickinger J, et al (2004). Hybrid PET.CT simulation for radiation treatment planning in head-andneck cancers: a brief technical report. Int J Radiat Oncol Biol Phys, 60, 1419-24. https://doi.org/10.1016/j.ijrobp.2004.05.037
- Kang PM, Seo WI, Lee SS, et al (2014). Incidental abnormal fdg uptake in the prostate on 18-fluoro- 2-deoxyglucose positron emission tomography-computed tomography scans. Asian Pac J Cancer Prev, 15, 8699-703. https://doi.org/10.7314/APJCP.2014.15.20.8699
- Kim SY, Roh JL, Yeo NK, et al (2014). Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol, 18, 1698-703.
- Koc ZP, Balci TA (2011). Bas ve boyun tumorlerinde positron emisyon tomografi/bilgisayarli tomografi (PET/BT). Firat Tip Dergisi, 16, 194-8
- McGuirt WF, Williams DW III, Keyes JW Jr, et al (1995). A comparative diagnostic study of head and neck nodal metastazes using positron emission tomography. Laryngoscope, 105, 373-75. https://doi.org/10.1288/00005537-199504000-00006
- Mutlu H, Buyukcelik A, Erden A, et al (2013). Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival. Asian Pac J Cancer Prev, 14, 3743-6 https://doi.org/10.7314/APJCP.2013.14.6.3743
- Nestle U, Kremp S, Schaefer-Schuler A, et al (2005). Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med, 46, 1342-48.
- Paulino AC, Johnstone PA (2004). FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys, 59, 4-5. https://doi.org/10.1016/j.ijrobp.2003.10.045
- Paulino AC, Koshy M, Howell R, et al (2005). Comparison of CTand FDG.PET-defined gross tumor volume in intensitymodulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 61, 1385-92. https://doi.org/10.1016/j.ijrobp.2004.08.037
- Scarfone C, Lavely WC, Cmelak AJ, et al (2004). Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med, 45, 543.52.
- Schwartz DL, Ford E, Rajendran J, et al (2005). FDG.PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 61, 129-36 https://doi.org/10.1016/j.ijrobp.2004.03.040
- Suit H (1996): Assessment of the Impact of Local Control on Clinical Outcome. In, Meyer JL, Purdy JA: Frontiers of Radiationtherapy and Oncology (3-D Conformal Radiotherapy: A new era in the irradiation of cancer). Basel: Karger, 17.
- Tan R, Yao SZ, Huang ZQ, et al (2014). Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer. Asian Pac J Cancer Prev, 15, 7719-24 https://doi.org/10.7314/APJCP.2014.15.18.7719
- Xu GZ, Guan DJ, He ZY (2011). (18) FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol, 47, 560-65. https://doi.org/10.1016/j.oraloncology.2011.04.021
- Van Baardwijk A (2004). Comparison of clinical target volume in PET.CT and CT-scan based treatment planning in patients in patients with head and neck cancer. ESTRO, 23, 177.